E
ZYUS Life Sciences Corporation ZYUS.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Revenue 36.13% 34.60% 22.34% 13.58% 7.58%
Total Other Revenue -- -- -- -- --
Total Revenue 36.13% 34.60% 22.34% 13.58% 7.58%
Cost of Revenue 260.32% 280.18% 281.07% 144.43% 42.51%
Gross Profit -487.63% -529.43% -548.94% -206.65% -112.06%
SG&A Expenses 5.75% 18.90% 46.99% 29.67% 2.87%
Depreciation & Amortization -3.40% -12.13% -27.00% -26.29% -33.96%
Other Operating Expenses 38.31% 7.65% 23.82% -8.13% -74.16%
Total Operating Expenses 21.79% 24.03% 30.01% 12.11% -21.48%
Operating Income -21.48% -23.82% -30.18% -12.09% 21.93%
Income Before Tax -72.76% -53.04% -90.80% -89.18% 10.49%
Income Tax Expenses -9,702.05% -10,353.77% -10,542.82% -9,410.84% 20.07%
Earnings from Continuing Operations -49.32% -32.38% -67.59% -66.91% 10.46%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -49.32% -32.38% -67.59% -66.91% 10.46%
EBIT -21.48% -23.82% -30.18% -12.09% 21.93%
EBITDA -26.00% -32.16% -47.94% -22.91% 18.43%
EPS Basic 5.27% 23.30% -3.16% -18.88% 10.87%
Normalized Basic EPS 45.15% 51.60% 35.65% 19.69% 9.72%
EPS Diluted 3.93% 22.22% -3.96% -19.23% 11.44%
Normalized Diluted EPS 45.15% 51.60% 35.65% 19.69% 9.72%
Average Basic Shares Outstanding 47.39% 74.51% 66.39% 31.83% 5.09%
Average Diluted Shares Outstanding 47.39% 74.51% 66.39% 31.83% 5.09%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings